Literature DB >> 31639705

Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer Assay.

Adrienne Tin1,2, Bing Yu3, Jianzhong Ma3, Kunihiro Masushita4,2, Natalie Daya4,2, Ron C Hoogeveen5, Christie M Ballantyne5, David Couper6, Casey M Rebholz4,2, Morgan E Grams4,7, Alvaro Alonso8, Thomas Mosley9, Gerardo Heiss10, Peter Ganz11, Elizabeth Selvin4,2, Eric Boerwinkle3,12, Josef Coresh4,2.   

Abstract

BACKGROUND: There is growing interest in the use of multiplexed aptamer-based assays for large-scale proteomic studies. However, the analytic, short- and long-term variation of the measured proteins is largely uncharacterized.
METHODS: We quantified 4001 plasma protein analytes from 42 participants in the Atherosclerosis Risk in Communities (ARIC) Study in split samples and at multiple visits using a multiplexed modified aptamer assay. We calculated the CV, Spearman correlation, and intraclass correlation (ICC) between split samples and evaluated the short-term (4-9 weeks) and long-term (approximately 20 years) variability using paired t-tests with log-transformed protein concentrations and Bonferroni-corrected significance thresholds. We performed principal component (PC) analysis of protein analyte concentrations and evaluated their associations with age, sex, race, and estimated glomerular filtration rate (eGFR).
RESULTS: The mean baseline age was 57 years at the first visit, 43% of participants were male and 57% were white. Among 3693 protein analytes that passed quality control, half (n = 1846) had CVs < 5.0%, Spearman correlations > 0.89, and ICCs > 0.96 among the split samples. Over the short term, only 1 analyte had a statistically significant difference between the 2 time points, whereas, over approximately 20 years, 866 analytes (23.4%) had statistically significant differences (P < 1.4 × 10-5, 681 increased, 185 decreased). PC1 had high correlations with age (-0.73) and eGFR (0.60). PC2 had moderate correlation with male sex (0.18) and white race (0.31).
CONCLUSIONS: Multiplexed modified aptamer technology can assay thousands of proteins with excellent precision. Our results support the potential for large-scale studies of the plasma proteome over the lifespan.
© 2018 American Association for Clinical Chemistry.

Entities:  

Year:  2019        PMID: 31639705      PMCID: PMC6814271          DOI: 10.1373/jalm.2018.027086

Source DB:  PubMed          Journal:  J Appl Lab Med        ISSN: 2475-7241


  25 in total

Review 1.  Established and emerging markers of kidney function.

Authors:  Michael A Ferguson; Sushrut S Waikar
Journal:  Clin Chem       Date:  2012-02-06       Impact factor: 8.327

2.  Development of proteome-wide binding reagents for research and diagnostics.

Authors:  Michael J Taussig; Ronny Schmidt; Elizabeth A Cook; Oda Stoevesandt
Journal:  Proteomics Clin Appl       Date:  2013-12       Impact factor: 3.494

3.  Genetic Architecture of the Cardiovascular Risk Proteome.

Authors:  Mark D Benson; Qiong Yang; Debby Ngo; Yineng Zhu; Dongxiao Shen; Laurie A Farrell; Sumita Sinha; Michelle J Keyes; Ramachandran S Vasan; Martin G Larson; J Gustav Smith; Thomas J Wang; Robert E Gerszten
Journal:  Circulation       Date:  2017-12-19       Impact factor: 29.690

Review 4.  Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.

Authors:  J Gustav Smith; Robert E Gerszten
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

Review 5.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

6.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

7.  Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Authors:  Jasmine Grewal; Robert S McKelvie; Hans Persson; Peter Tait; Jonas Carlsson; Karl Swedberg; Jan Ostergren; Eva Lonn
Journal:  Am J Cardiol       Date:  2008-07-09       Impact factor: 2.778

8.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.

Authors:  Mary Ann De Groote; Michael Higgins; Thomas Hraha; Kirsten Wall; Michael L Wilson; David G Sterling; Nebojsa Janjic; Randall Reves; Urs A Ochsner; Robert Belknap
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

10.  Genomic atlas of the human plasma proteome.

Authors:  Benjamin B Sun; Joseph C Maranville; James E Peters; David Stacey; James R Staley; James Blackshaw; Stephen Burgess; Tao Jiang; Ellie Paige; Praveen Surendran; Clare Oliver-Williams; Mihir A Kamat; Bram P Prins; Sheri K Wilcox; Erik S Zimmerman; An Chi; Narinder Bansal; Sarah L Spain; Angela M Wood; Nicholas W Morrell; John R Bradley; Nebojsa Janjic; David J Roberts; Willem H Ouwehand; John A Todd; Nicole Soranzo; Karsten Suhre; Dirk S Paul; Caroline S Fox; Robert M Plenge; John Danesh; Heiko Runz; Adam S Butterworth
Journal:  Nature       Date:  2018-06-06       Impact factor: 49.962

View more
  20 in total

1.  Polygenic Risk Scores for Kidney Function and Their Associations with Circulating Proteome, and Incident Kidney Diseases.

Authors:  Zhi Yu; Jin Jin; Adrienne Tin; Anna Köttgen; Bing Yu; Jingsha Chen; Aditya Surapaneni; Linda Zhou; Christie M Ballantyne; Ron C Hoogeveen; Dan E Arking; Nilanjan Chatterjee; Morgan E Grams; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2021-09-21       Impact factor: 10.121

2.  Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.

Authors:  Jigyasha Timsina; Duber Gomez-Fonseca; Lihua Wang; Anh Do; Dan Western; Ignacio Alvarez; Miquel Aguilar; Pau Pastor; Rachel L Henson; Elizabeth Herries; Chengjie Xiong; Suzanne E Schindler; Anne M Fagan; Randall J Bateman; Martin Farlow; John C Morris; Richard Perrin; Krista Moulder; Jason Hassenstab; Jasmeer Chhatwal; Hiroshi Mori; Yun Ju Sung; Carlos Cruchaga
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  Long-term changes in plasma proteomic profiles in premenopausal and postmenopausal Black and White women: the Atherosclerosis Risk in Communities study.

Authors:  Duke Appiah; Pamela J Schreiner; James S Pankow; Guy Brock; Weihong Tang; Faye L Norby; Erin D Michos; Christie M Ballantyne; Aaron R Folsom
Journal:  Menopause       Date:  2022-08-20       Impact factor: 3.310

4.  Proteins Associated with Risk of Kidney Function Decline in the General Population.

Authors:  Morgan E Grams; Aditya Surapaneni; Jingsha Chen; Linda Zhou; Zhi Yu; Diptavo Dutta; Paul A Welling; Nilanjan Chatterjee; Jingning Zhang; Dan E Arking; Teresa K Chen; Casey M Rebholz; Bing Yu; Pascal Schlosser; Eugene P Rhee; Christie M Ballantyne; Eric Boerwinkle; Pamela L Lutsey; Thomas Mosley; Harold I Feldman; Ruth F Dubin; Peter Ganz; Hongzhe Lee; Zihe Zheng; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2021-09       Impact factor: 14.978

5.  Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Brian T Steffen; Weihong Tang; Pamela L Lutsey; Ryan T Demmer; Elizabeth Selvin; Kunihiro Matsushita; Alanna C Morrison; Weihua Guan; Mary R Rooney; Faye L Norby; Nathan Pankratz; David Couper; James S Pankow
Journal:  Diabetologia       Date:  2022-10-04       Impact factor: 10.460

6.  Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients.

Authors:  Richard X Liu; Heather R Thiessen-Philbrook; Ramachandran S Vasan; Josef Coresh; Peter Ganz; Joseph V Bonventre; Paul L Kimmel; Chirag R Parikh
Journal:  Transl Res       Date:  2021-07-31       Impact factor: 7.012

7.  Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction.

Authors:  Hongsheng Gui; Ruicong She; Jasmine Luzum; Jia Li; Timothy D Bryson; Yigal Pinto; Hani N Sabbah; L Keoki Williams; David E Lanfear
Journal:  Circ Genom Precis Med       Date:  2021-05-17

8.  Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women.

Authors:  Xiaoming Jia; Caroline Sun; Olive Tang; Ivan Gorlov; Vijay Nambi; Salim S Virani; Dennis T Villareal; George E Taffet; Bing Yu; Jan Bressler; Eric Boerwinkle; B Gwen Windham; James A de Lemos; Kunihiro Matsushita; Elizabeth Selvin; Erin D Michos; Ron C Hoogeveen; Christie M Ballantyne
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

9.  Crowdsourcing assessment of maternal blood multi-omics for predicting gestational age and preterm birth.

Authors:  Adi L Tarca; Bálint Ármin Pataki; Roberto Romero; Marina Sirota; Yuanfang Guan; Rintu Kutum; Nardhy Gomez-Lopez; Bogdan Done; Gaurav Bhatti; Thomas Yu; Gaia Andreoletti; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chaur-Dong Hsu; Nima Aghaeepour; Gustavo Stolovitzky; Istvan Csabai; James C Costello
Journal:  Cell Rep Med       Date:  2021-06-15

Review 10.  The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3/8.

Authors:  Jacqueline D Wright; Aaron R Folsom; Josef Coresh; A Richey Sharrett; David Couper; Lynne E Wagenknecht; Thomas H Mosley; Christie M Ballantyne; Eric A Boerwinkle; Wayne D Rosamond; Gerardo Heiss
Journal:  J Am Coll Cardiol       Date:  2021-06-15       Impact factor: 27.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.